1. FP205CRYSTAL NEPHROTOXICITY INVOLVES TWO DISTINCT MOLECULAR PATHWAYS OF REGULATED NECROSIS. (18th May 2018) Authors: Mulay, S; Foresto-Neto, O; Honarpisheh, M; Shi, C; Steiger, S; Popper, B; Buhl, E; Boor, P; Anders, H Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FP205CRYSTAL NEPHROTOXICITY INVOLVES TWO DISTINCT MOLECULAR PATHWAYS OF REGULATED NECROSIS. (18th May 2018) Authors: Mulay, S; Foresto-Neto, O; Honarpisheh, M; Shi, C; Steiger, S; Popper, B; Buhl, E; Boor, P; Anders, H Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The SGLT2 inhibitor ertugliflozin causes a switch of cardiac substrate utilization leading to reduced cardiac mTOR-signaling, unfolded protein response and apoptosis. (14th October 2021) Authors: Moellmann, J; Mann, P; Krueger, K; Klinkhammer, B; Boor, P; Marx, N; Lehrke, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗